SMTL ID : 7km5.1 (1 other biounit)

Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.19 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: F.20, G.21, F.24, N.25 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ye, G. et al., The development of Nanosota - 1 as anti-SARS-CoV-2 nanobody drug candidates. Elife (2021)

Release Date

2021-08-04

Peptides

Spike protein S1: A
nanobody: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

Spike protein S1

nanobody

Related Entries With Identical Sequence